Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma
It has been demonstrated that mTOR/p70S6K pathway was abnormally activated in many cancers and rapamycin and its analogs can restrain tumor growth through inhibiting this pathway, but some tumors including esophageal squamous cell carcinoma (ESCC) appear to be insensitive to rapamycin in recent stud...
Saved in:
Main Authors: | Zhaoming Lu, Kezheng Peng, Ning Wang, Hong-Min Liu, Guiqin Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/7828916 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Downregulation of S100 Calcium Binding Protein A9 in Esophageal Squamous Cell Carcinoma
by: Harsh Pawar, et al.
Published: (2015-01-01) -
MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma
by: Kah Young Lee, et al.
Published: (2025-01-01) -
Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage
by: Ning Du, et al.
Published: (2023-01-01) -
Esophageal Squamous Cell Carcinoma Presenting with Streptococcus intermedius Cerebral Abscess
by: Rabih Nayfe, et al.
Published: (2017-01-01) -
PARylation of HMGA1 desensitizes esophageal squamous cell carcinoma to olaparib
by: Xin‐Yuan Lei, et al.
Published: (2024-12-01)